Nanomedicine Market Size, Share & Industry Analysis, By Type (Therapeutics {Biologics and Small Molecules}, Diagnostics {IVD, Imaging, and Others}, and Medical Devices {Regenerative Medicine, and Implants}), By Molecule Type (Nanoparticles {Lipid Based, Polymers & Polymer Drug Conjugates, Inorganic Nanoparticles}, Nanoshells, Nanotubes, and Nanodevices) By Application (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Immunology, Infectious Diseases), By End-user (Hospitals and Clinics, Diagnostics Laboratories, Research and Academic Institutes), and Regional Forecast, 2025-2032

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI110983

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Disease, By Key Countries/ Regions, 2024
2. Overview: Application of Nanomedicine in Healthcare
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches etc.)
4. Pipeline Analysis
5. Impact of COVID-19 on the Global Nanomedicine Market
Global Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Nanomedicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Therapeutics
    1. Biologics
    2. Small Molecules
  2. Diagnostics
    1. IVD
    2. Imaging
    3. Others
  3. Medical Devices
    1. Regenerative Medicine
    2. Implants
2. Market Analysis, Insights and Forecast – By Molecule Type
  1. Nanoparticles
    1. Lipid Based
    2. Polymers & Polymer Drug Conjugates
    3. Inorganic Nanoparticles
    4. Others
  2. Nanoshells
  3. Nanotubes
  4. Nanodevices
3. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurodegenerative Diseases
  3. Cardiovascular Diseases
  4. Immunology
  5. Infectious Diseases
  6. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals and Clinics
  2. Diagnostics Laboratories
  3. Research and Academic Institutes
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2023)
2. Company Profiles
  1. Gilead Sciences, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Teva Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Pfizer Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Jazz Pharmaceuticals plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Nanospectra Biosciences, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Janssen Pharmaceuticals, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Amgen Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Arrowhead Pharmaceuticals, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Ipsen Pharma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Nanomedicine Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Nanomedicine Market Value Share (%), by Type, 2023 & 2032

Figure 3: Global Nanomedicine Market Value Share (%), by Molecule Type, 2023 & 2032

Figure 4: Global Nanomedicine Market Value Share (%), by Application, 2023 & 2032

Figure 5: Global Nanomedicine Market Value Share (%), by End-user, 2023 & 2032

Figure 6: Global Nanomedicine Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Nanomedicine Market Value (USD billion), by Type, 2023 & 2032

Figure 8: North America Nanomedicine Market Value Share (%), by Type, 2023

Figure 9: North America Nanomedicine Market Value (USD billion), by Molecule Type, 2023 & 2032

Figure 10: North America Nanomedicine Market Value Share (%), by Molecule Type, 2023

Figure 11: North America Nanomedicine Market Value (USD billion), by Application, 2023 & 2032

Figure 12: North America Nanomedicine Market Value Share (%), by Application, 2023

Figure 13: North America Nanomedicine Market Value (USD billion), by End-user, 2023 & 2032

Figure 14: North America Nanomedicine Market Value Share (%), by End-user, 2023

Figure 15: North America Nanomedicine Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Nanomedicine Market Value Share (%), By Country, 2023

Figure 17: Europe Nanomedicine Market Value (USD billion), by Type, 2023 & 2032

Figure 18: Europe Nanomedicine Market Value Share (%), by Type, 2023

Figure 19: Europe Nanomedicine Market Value (USD billion), by Molecule Type, 2023 & 2032

Figure 20: Europe Nanomedicine Market Value Share (%), by Molecule Type, 2023

Figure 21: Europe Nanomedicine Market Value (USD billion), by Application, 2023 & 2032

Figure 22: Europe Nanomedicine Market Value Share (%), by Application, 2023

Figure 23: Europe Nanomedicine Market Value (USD billion), by End-user, 2023 & 2032

Figure 24: Europe Nanomedicine Market Value Share (%), by End-user, 2023

Figure 25: Europe Nanomedicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Nanomedicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Nanomedicine Market Value (USD billion), by Type, 2023 & 2032

Figure 28: Asia Pacific Nanomedicine Market Value Share (%), by Type, 2023

Figure 29: Asia Pacific Nanomedicine Market Value (USD billion), by Molecule Type, 2023 & 2032

Figure 30: Asia Pacific Nanomedicine Market Value Share (%), by Molecule Type, 2023

Figure 31: Asia Pacific Nanomedicine Market Value (USD billion),by Application, 2023 & 2032

Figure 32: Asia Pacific Nanomedicine Market Value Share (%), by Application, 2023

Figure 33: Asia Pacific Nanomedicine Market Value (USD billion), by End-user, 2023 & 2032

Figure 34: Asia Pacific Nanomedicine Market Value Share (%), by End-user, 2023

Figure 35: Asia Pacific Nanomedicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Nanomedicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Nanomedicine Market Value (USD billion), by Type, 2023 & 2032

Figure 38: Latin America Nanomedicine Market Value Share (%), by Type, 2023

Figure 39: Latin America Nanomedicine Market Value (USD billion), by Molecule Type, 2023 & 2032

Figure 40: Latin America Nanomedicine Market Value Share (%), by Molecule Type, 2023

Figure 41: Latin America Nanomedicine Market Value (USD billion), by Application, 2023 & 2032

Figure 42: Latin America Nanomedicine Market Value Share (%), by Application, 2023

Figure 43: Latin America Nanomedicine Market Value (USD billion), by End-user, 2023 & 2032

Figure 44: Latin America Nanomedicine Market Value Share (%), by End-user, 2023

Figure 45: Latin America Nanomedicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Nanomedicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Nanomedicine Market Value (USD billion), by Type, 2023 & 2032

Figure 48: Middle East & Africa Nanomedicine Market Value Share (%), by Type, 2023

Figure 49: Middle East & Africa Nanomedicine Market Value (USD billion), by Molecule Type, 2023 & 2032

Figure 50: Middle East & Africa Nanomedicine Market Value Share (%), by Molecule Type, 2023

Figure 51: Middle East & Africa Nanomedicine Market Value (USD billion), by Application, 2023 & 2032

Figure 52: Middle East & Africa Nanomedicine Market Value Share (%), by Application, 2023

Figure 53: Middle East & Africa Nanomedicine Market Value (USD billion), by End-user, 2023 & 2032

Figure 54: Middle East & Africa Nanomedicine Market Value Share (%), by End-user, 2023

Figure 55: Middle East & Africa Nanomedicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Nanomedicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Nanomedicine Market Share (%), By Company, 2023

List of Tables

Table 1: Global Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 3: Global Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 4: Global Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 5: Global Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019–2032

Table 6: Global Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 7: Global Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 8: Global Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 9: Global Nanomedicine Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 10: North America Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 11: North America Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 12: North America Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 13: North America Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 14: North America Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019-2032

Table 15: North America Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 16: North America Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 17: North America Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 18: North America Nanomedicine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 19: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 20: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 21: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 22: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 23: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019-2032

Table 24: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 25: Europe Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 26: Europe Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 27: Europe Nanomedicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 28: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 29: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 30: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 31: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 32: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019-2032

Table 33: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 34: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 35: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 36: Asia Pacific Nanomedicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 37: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 38: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 39: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 40: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 41: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019-2032

Table 42: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 43: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 44: Latin America Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 45: Latin America Nanomedicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 46: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 47: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019–2032

Table 48: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019–2032

Table 49: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Medical Devices, 2019–2032

Table 50: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Molecule Type, 2019-2032

Table 51: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Nanoparticles, 2019–2032

Table 52: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 53: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 54: Middle East & Africa Nanomedicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR:2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 200

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]